General Manager, Pharmaceutical Development Department, Central Research Laboratory, Kobayashi Pharmaceutical Co.
Aiko Watanabe joined Kobayashi Pharmaceutical in 1998. Currently, she runs the Pharmaceutical Development Department, and is responsible for clinical research, switch OTC drug development, and the application for approval of new OTC drugs and quasi-drugs. She has worked on the development of products such as "Feminina", an OTC drug especially designed for the delicate zone, "Inochi no Haha", a women's health drug, and "Keshimin", a skin care product.
Since 2007, Ms. Watanabe has been involved in the establishment of a clinical trial division with the aim of expanding self-medication and developing a wide range of useful OTC drugs.